Rain Oncology Inc. Retained Earnings
Rain Oncology Inc. had Retained Earnings of -$215.27 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-09
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$215.27M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$208.24M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$186.17M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$165.69M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-09-30 | -$215.27M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$208.24M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$186.17M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$165.69M 10-Q · filed 2023-11-09 |
| 2022-09-30 | -$143.01M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$124.97M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$107.36M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$89.96M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$71.98M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$53.55M 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$45.37M 10-Q · filed 2021-05-25 |
| 2020-12-31 | -$38.57M 10-K · filed 2022-03-03 |